Latest in Merck’s
Sort by
5 items
-
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.Business - CNBC - 2 hours ago -
Merck’s stock slides as Q3 earnings beat estimates, but company lowers guidance
Merck’s stock fell Thursday morning, despite the company beating profit and sales estimates for the third quarter.Business - MarketWatch - 5 hours ago -
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.Business - CNBC - October 18 -
Merck KGaA Shares Jump on Expectations of AI Boost
The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously expected over the medium term.Business - The Wall Street Journal - October 17